ArticleWorld journal of gastrointestinal pharmacology and therapeutics2025
Comparison of endoscopic retrograde cholangiopancreatography drainage
Article in World journal of gastrointestinal pharmacology and therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere acute cholangitis is a potentially life-threatening disease in low-middle income countries (LMIC). Due to limited endoscopic services, these patients mostly undergo percutaneous transhepatic biliary drainage (PTBD). Studies from developed countries reported more complications with PTBD as compared with endoscopic retrograde cholangiopancreatography (ERCP).
aimTo compare safety, therapeutic success, and survival among the PTBD and ERCP procedure in severe cholangitis in LMIC.
methodsA retrospective study was conducted in the Aga Khan University Hospital from January 2017 to December 2023. All patients who had severe acute cholangitis and underwent ERCP or PTBD were included. Patients were followed for complications, procedure success, and mortality. Data was gathered through an electronic medical record system and analyzed using
resultsA total of 33 patients were recruited, consisting of 12 females and 21 males with a mean age of 61 years. Among these participants, 12 patients underwent ERCP, and the remaining 21 patients underwent PTBD. Therapeutic success was seen more in the ERCP group [11/12 (97.1%)] than in the PTBD group [12/21 patients (57.1%)]. Post-procedure complications were seen in both groups; however, more were observed in the PTBD cohort with a significant
conclusionFewer post-procedure complications and deaths were observed after ERCP than after PTBD, laying the foundation for large prospective studies and shifting the local paradigm of acute cholangitis treatment in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.